1. Früh, Simon, Boudkkazi, Sami, Koppensteiner, Peter, Shigemoto, Ryuichi, Bettler, Bernhard. 2024. Monoallelic de novo AJAP1 loss-of-function variants disrupt trans-synaptic control of neurotransmitter release. In Science advances, 10, eadk5462. doi:10.1126/sciadv.adk5462. https://pubmed.ncbi.nlm.nih.gov/38985877/
2. Cogdell, David, Chung, Woonbok, Liu, Yuexin, Fuller, Gregory N, Zhang, Wei. . Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma. In Chinese journal of cancer, 30, 247-53. doi:. https://pubmed.ncbi.nlm.nih.gov/21439246/
3. Han, Lei, Zhang, Kai-Liang, Zhang, Jun-Xia, Kang, Chun-Sheng, Adamson, David Cory. 2014. AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganization. In CNS neuroscience & therapeutics, 20, 429-37. doi:10.1111/cns.12232. https://pubmed.ncbi.nlm.nih.gov/24483339/
4. Lin, Ningjing, Di, Chunhui, Bortoff, Kathy, Gregory, Simon, Adamson, David Cory. 2012. Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma. In Molecular cancer research : MCR, 10, 208-17. doi:10.1158/1541-7786.MCR-10-0109. https://pubmed.ncbi.nlm.nih.gov/22241217/
5. Zeng, Liang, Fee, Brian E, Rivas, Miriam V, Lin, James, Adamson, David Cory. 2014. Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review). In International journal of oncology, 45, 13-7. doi:10.3892/ijo.2014.2425. https://pubmed.ncbi.nlm.nih.gov/24807315/
智鼠故事 
